Table 2.
Class | Variable | Temporary SBS (n = 26) | SBS-JC (n = 21) |
SBS-JIC (n = 12) |
SBS-I (n = 6) |
SBS + TED (n = 5) |
p-Value |
---|---|---|---|---|---|---|---|
Demo-graphics | Age (years) | 58 (49; 69) | 64 (45; 74) | 57 (43; 69) | 50 (32; 63) | 56 (47;64) | 0.57 |
Gender (female) | 13 (50) | 17 (81) | 8 (61.5) | 1 (16.7) | 1 (20) | 0.02 | |
Etiology (%) | Ischemia (A/V) | 11/6 (65.4) | 10/0 (47.6) | 3/4 (53.8) | 1 (16.7) | 1/1 (40) | 0.25 |
IBD (CD/UC) | 6/1 (26.9) | 4/0 (19) | 1 (7.7) | 5 (83.3) | 0 (0) | <0.01 | |
Radiation | 1 (3.8) | 3 (14.3) | 2 (15.4) | 0 (0) | 0 (0) | 0.48 | |
Surgical/adhesion | 1 (3.8) | 3 (14.3) | 2 (15.4) | 0 (0) | 3 (60) | 0.01 | |
Trauma/volvulus | 0 (0) | 1 (4.8) | 1 (7) | 0 (0) | 0 (0) | 0.65 | |
IF class (%) | FE | 2 (7.7) | 0 (0) | 0 (0) | 3 (50) | 0 (0) | <0.001 |
PN1 (≤1 L) | 2 (7.7) | 2 (9.5) | 0 (0) | 0 (0) | 0 (0) | 0.69 | |
PN2 (1–2 L) | 10 (38.5) | 8 (38.1) | 4 (30.8) | 3 (50) | 0 (0) | 0.46 | |
PN3 (2–3 L) | 8 (30.8) | 4 (19) | 2 (15.4) | 0 (0) | 1 (20) | 0.50 | |
PN4 (>3 L) | 4 (15.4) | 7 (33.3) | 7 (53.8) | 0 (0) | 4 (80) | <0.01 | |
Total SB (cm) | 300 (240; 330) | 105 (70; 160) | 160 (70; 190) | 250 (200; 300) | 75 (69; 80) | <0.0001 | |
Anatomy | Ileum (cm) | 120 (13; 235) | 0 (0; 0) | 50 (25; 120) | NA | 0 (0; 10) | <0.0001 |
Colon (%) | 100 (86; 100) | 75 (70; 90) | 100 (100; 100) | NA | 80 (63; 88) | <0.0001 | |
Duration | IVS (weeks) | 10.5 (7; 14) | 40 (28.5; 67) | 23 (14.5; 64) | 62.5 (35; 141) | 166 (93.5; 376) | <0.0001 |
FU (weeks) | 29 (15; 48) | 39 (12.5:84.5) | 22 (15; 83.5) | 40.5 (9; 45) | 137 (76; 156) | 0.04 |
Continuous data were reported as median (IQR) and categorical data as proportions (%) and analyzed using Kruskal–Wallis and chi-square tests, respectively. Abbreviations: arterial (A), Crohn’s disease (CD), fluids and electrolytes (FE), follow-up (FU), inflammatory bowel diseases (IBD), intestinal failure (IF), intravenous support (IVS), parenteral nutrition (PN), small bowel (SB), short bowel syndrome (SBS), ileostomy (SBS-I), jejuno-colic anastomosis (SBS-JC), jejuno-ileal anastomosis (SBS-JIC), teduglutide (TED), ulcerative colitis (UC), and venous (V).